Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2017 | 1 |
2018 | 1 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Development of a cobalt(iii)-based ponatinib prodrug system.
Inorg Chem Front. 2021 Mar 30;8(10):2468-2485. doi: 10.1039/d1qi00211b.
Inorg Chem Front. 2021.
PMID: 34046181
Free PMC article.
Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074.
Englinger B, Kallus S, Senkiv J, Laemmerer A, Moser P, Gabler L, Groza D, Kowol CR, Heffeter P, Grusch M, Berger W.
Englinger B, et al. Among authors: moser p.
Cells. 2018 Dec 8;7(12):259. doi: 10.3390/cells7120259.
Cells. 2018.
PMID: 30544798
Free PMC article.
Item in Clipboard
Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib.
Englinger B, Laemmerer A, Moser P, Kallus S, Röhrl C, Pirker C, Baier D, Mohr T, Niederstaetter L, Meier-Menches SM, Gerner C, Gabler L, Gojo J, Timelthaler G, Senkiv J, Jäger W, Kowol CR, Heffeter P, Berger W.
Englinger B, et al. Among authors: moser p.
Int J Cancer. 2020 Sep 15;147(6):1680-1693. doi: 10.1002/ijc.32924. Epub 2020 Mar 2.
Int J Cancer. 2020.
PMID: 32064608
Free PMC article.
Item in Clipboard
Pythons metabolize prey to fuel the response to feeding.
Starck JM, Moser P, Werner RA, Linke P.
Starck JM, et al. Among authors: moser p.
Proc Biol Sci. 2004 May 7;271(1542):903-8. doi: 10.1098/rspb.2004.2681.
Proc Biol Sci. 2004.
PMID: 15255044
Free PMC article.
Item in Clipboard
Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer.
Englinger B, Kallus S, Senkiv J, Heilos D, Gabler L, van Schoonhoven S, Terenzi A, Moser P, Pirker C, Timelthaler G, Jäger W, Kowol CR, Heffeter P, Grusch M, Berger W.
Englinger B, et al. Among authors: moser p.
J Exp Clin Cancer Res. 2017 Sep 7;36(1):122. doi: 10.1186/s13046-017-0592-3.
J Exp Clin Cancer Res. 2017.
PMID: 28882160
Free PMC article.
Item in Clipboard
Cite
Cite